Transient Hypothyroxinemia of Prematurity (THOP) Withdrawn Phase 3 Trials for Potassium Iodide (DB06715)

Back to Transient Hypothyroxinemia of Prematurity (THOP)

Also known as: Transient Hypothyroxinemia of Prematurity / Transient hypothyroxinaemia of prematurity

IndicationStatusPhase
DBCOND0069872 (Transient Hypothyroxinemia of Prematurity (THOP))Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02103998Study of Thyroid Hormones in PrematuresTreatment